A new study finds superinfection may be as common as initial HIV infection and is not limited to high risk-populations.
Posts Tagged ‘Sexually Transmitted Diseases’
A new discovery may shed light on the mystery of why some people infected with HIV are better able to control the virus, live longer and have fewer associated health problems than others who have been infected as long. It also provides a potential new target for developing therapies or vaccines.
Researchers have found that herpes and other viruses that attack the nervous system may thrive by disrupting cell function in order to hijack a neuron’s internal transportation network and spread to other cells.
Antibodies that help to stop the HIV virus have been found in breast milk. Researchers have isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, and showed that the B cells in breast milk can generate neutralizing antibodies that may inhibit the virus that causes AIDS.
Clinician researchers have developed a vaccine that acts simultaneously against HIV-1 and M. tuberculosis). An estimated 14 million people worldwide are coinfected with the two pathogens.
In the United States, where blacks bear a disproportionate burden of the HIV/AIDS epidemic, black religious institutions could help turn the tide. In a new study based on dozens of interviews and focus groups with 38 of Philadelphia’s most influential black religious leaders, physicians and public health researchers find that traditional barriers to preaching about HIV prevention could give way to faith-friendly messages about getting tested and staying on treatment.
Early elevated hiv infection risk in some step study participants who received vaccine; risk decreased over timeMonday, May 7th, 2012
A long-term follow-up analysis of participants in the Step Study, an international HIV-vaccine trial, has confirmed that certain subgroups of male study participants were at higher risk of becoming infected after receiving the experimental vaccine compared to those who received a placebo. The vaccine used in the study did not contain the HIV virus, but it did contain HIV genes which were delivered to cells using a vector that employed a type of cold virus known as adenovirus serotype 5 (Ad5).
The proportion of insured girls and young women completing the human papillomavirus (HPV) vaccine among those who initiated the series has dropped significantly — as much as 63 percent — since the vaccine was approved in 2006, according to new research.
Researchers are a step closer to launching human clinical trials involving the use of an innovative stem cell therapy to fight the virus that causes AIDS.
Researchers have discovered small molecules that kill cancer cells caused by infection with human papillomavirus. Their results, in both cell and mouse models, demonstrate that the small molecule inhibitors protect a tumor-suppressing protein targeted by viral proteins, thus killing the infected tumor cells. The researchers believe that, with further testing and refinement, their inhibitors could provide a therapeutic for HPV-caused tumors, such as those seen in cervical cancer.